Physician profile
Lynn N Smith
NPI 1295730372
$2,471.39
in general payments reported to CMS, 2019-2025
23 companies · $27.03 in 2025
The $27.03 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $779 · 2021: $518 · 2025: $27.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $533.83 | 2019-2021 | |
| Lilly USA, LLC | $354.39 | 2019-2021 | |
| Glaxosmithkline, LLC. | $301.10 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.52 | 2019-2021 | |
| Novo Nordisk INC | $239.90 | 2019-2021 | |
| Pfizer INC. | $143.11 | 2019-2021 | |
| Esperion Therapeutics, INC. | $79.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $66.58 | 2019-2020 | |
| Mylan Specialty L.P. | $61.90 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $50.94 | 2019-2021 | |
| Philips North America LLC | $44.32 | 2020-2021 | |
| Amgen INC. | $42.44 | 2020 | |
| Sanofi-Aventis U.S. LLC | $37.31 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.46 | 2019 | |
| Merck Sharp & Dohme LLC | $35.10 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $31.62 | 2019 | |
| Terumo Medical Corporation | $27.03 | 2025 | Tr Band, Angio-Seal |
| Dexcom, INC. | $25.77 | 2021 | |
| Shire North American Group INC | $18.77 | 2019 | |
| Grifols USA, LLC | $17.69 | 2019 | |
| Resmed Corp | $15.78 | 2020 | |
| Sunovion Pharmaceuticals INC. | $13.59 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.